Cutler Group’s Proshares UltraPro NASDAQ Biotechnology UBIO Stock Holding History

Cutler Group’s Portfolio UBIO Stock Details UBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,521	Closed	-$49K	–	5013
2019 Q4	$49K	Buy	+1,521	New	+$40.4K	﹤0.01%	1650
2018 Q3	–	Sell	-100	Closed	-$4.04K	–	4999
2018 Q2	$3K	Sell	100 -300	-75%	-$9.35K	﹤0.01%	3488
2018 Q1	$12K	Hold	400	–	–	﹤0.01%	2694
2017 Q4	$13K	Buy	400 +300	+300%	+$10.2K	﹤0.01%	2952
2017 Q3	$3K	Buy	+100	New	+$3.48K	﹤0.01%	4940
2017 Q2	–	Sell	-1,733	Closed	-$48.6K	–	7458
2017 Q1	$47K	Buy	1,733 +598	+53%	+$15.8K	﹤0.01%	2480
2016 Q4	$23K	Buy	+1,135	New	+$26.9K	﹤0.01%	3343
2016 Q3	–	Sell	-5	Closed	-$142	–	7704
2016 Q2	$0	Sell	5 -2,294	-100%	-$58.1K	﹤0.01%	7606
2016 Q1	$54K	Sell	2,299 -671	-23%	-$18.5K	﹤0.01%	2258
2015 Q4	$171K	Buy	+2,970	New	+$157K	0.01%	1318

Other funds holding UBIO

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Cutler Group's UBIO Position: Q1 2020 in Review

Cutler Group sold out of Proshares UltraPro NASDAQ Biotechnology (UBIO) in Q1 2020, closing a stake of 1,521 shares — an estimated $49K sold.

Cutler Group first reported a position in UBIO in Q4 2015 and held it in 10 quarters. The position peaked at $171K in Q4 2015. 1 fund tracked by Wall St. Rank holds UBIO as of Q1 2020.

Cutler Group reported no remaining Proshares UltraPro NASDAQ Biotechnology position as of Q1 2020 after selling out during the quarter.
Cutler Group sold 1,521 Proshares UltraPro NASDAQ Biotechnology shares in Q1 2020, an estimated $49K.
Cutler Group first reported a position in Proshares UltraPro NASDAQ Biotechnology in Q4 2015 and held it in 10 quarters.
Cutler Group's Proshares UltraPro NASDAQ Biotechnology position peaked at $171K in Q4 2015.
1 fund tracked by Wall St. Rank held Proshares UltraPro NASDAQ Biotechnology as of Q1 2020.

Based on Cutler Group's 13F filing for Q1 2020, filed 7 May 2020.